The Ontario Bioscience Innovation Organization (OBIO), a membership-based not-for-profit organisation, is set to bring investors from around the world to its annual OBIO Investment Summit (OIS) and Early Technology Showcase (ETS), which showcases Canada’s leading innovations in health sciences, including biotech and medtech.
According to OBIO’s analysis, the registered investors have approximately USD52 billion combined in unallocated and available funds to invest during the summit.
The summit showcases investable companies, including the Early Technology Showcase, which this year, highlights 10 of Canada’s leading health research institutions presenting their latest breakthrough technologies, from mental health and cancer detection to AI and stem cell therapies.
Read more: Private Equity Wire
